|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Ribavirin. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (925)
Cases resulting in a serious event (918)
Cases resulting in death (57)
Cases resulting in life threatening events (47)
Cases resulting in hospitalization (480)
Cases resulting in disability (40)
Cases resulting in other serious reactions (537)
Below is a sample of reports where side effects / adverse reactions may be related to Ribavirin. For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 38 year old male receiving Ribavirin
Reported by a physician from Spain on 2007-10-31
Patient: 38 year old male, weighing 42.6 kg (93.7 pounds)
Adverse reactions / side effects: Subcutaneous Abscess
Adverse event resulted in: hospitalization
Suspect drug(s):
Enfuvirtide
Indication: Drug USE FOR Unknown Indication
Start date: 2006-10-04
PEG-Interferon A-2A (RO 25-8310)
Start date: 2006-12-07
Ribavirin
Administration route: Oral
Start date: 2006-12-07
Other drugs received by patient: Kaletra; Truvada
Adverse event in 52 year old female receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 52 year old female, weighing 70.3 kg (154.7 pounds)
Adverse reactions / side effects: Weight Decreased, Muscle Atrophy, Fall, Thinking Abnormal, Road Traffic Accident, Fatigue, Mood Altered, Balance Disorder, DRY Mouth, Dizziness, Brain Oedema, Depression, Hydrocephalus, Urinary Retention, Crying, Vomiting, Nausea, Anxiety, Anorexia, Memory Impairment, Gait Disturbance, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2006-11-02
End date: 2007-09-06
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-11-02
End date: 2007-09-06
Other drugs received by patient: Vicodin (Con.); Clonazepam (Con.); Corgard (Con.); Cymbalta (Con.); Fiorinal (Con.); Glyburide (Con.); Hyoscyamine (Con.); Lipitor (Con.); Meclizine (Con.); Metformin (Con.); Nexium (Con.); Promethazine (Con.); Singulair (Con.); Ibuprofen (Con.)
Adverse event in 43 year old male receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 43 year old male
Adverse reactions / side effects: Asthma, Anaemia, Blood Glucose Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Interferon A-2A (RO 25-8310)
Start date: 2007-08-16
Ribavirin
Start date: 2007-08-16
Adverse event in 55 year old male receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 55 year old male
Adverse reactions / side effects: Diabetes Mellitus, Coronary Artery Disease, Anxiety, Fatigue, Throat Irritation, Feeling Jittery, Chest Pain, Sinus Disorder, Arterial Occlusive Disease, Depression
Suspect drug(s):
Intron A
Indication: Hepatitis C
Start date: 2000-01-01
End date: 2000-01-01
Ribavirin
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2000-01-01
End date: 2000-01-01
Adverse event in 33 year old female receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 33 year old female
Adverse reactions / side effects: Migraine
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Interferon A-2A (RO 25-8310)
Start date: 2007-09-09
Ribavirin
Start date: 2007-09-09
Adverse event in 57 year old female receiving Ribavirin
Reported by a physician from United States on 2007-10-31
Patient: 57 year old female, weighing 63.0 kg (138.7 pounds)
Adverse reactions / side effects: Cellulitis, Blood Potassium Decreased, Pancytopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Infergen
Dosage: 15 ug;qd;sc
Indication: Hepatitis C
Start date: 2007-03-16
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-16
Other drugs received by patient: Allegra; Ambien CR
Adverse event in 57 year old male receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 57 year old male
Adverse reactions / side effects: Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
PEG-Interferon A-2A (RO 25-8310)
Start date: 2007-05-27
Ribavirin
Start date: 2007-05-27
Adverse event in 54 year old male receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 54 year old male
Adverse reactions / side effects: Blood Iron Decreased, White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Ascites, Hepatic Cirrhosis
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-08-31
End date: 2007-10-24
Ribavirin
Dosage: po
Administration route: Oral
Indication: Hepatitis
Start date: 2007-08-31
End date: 2007-10-24
Adverse event in male receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: male
Adverse reactions / side effects: Psychotic Disorder, Paranoia
Suspect drug(s):
Intron A
Dosage: tiw;sc
Indication: Hepatitis C
Start date: 1997-01-01
Ribavirin
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 1997-01-01
Adverse event in 45 year old male receiving Ribavirin
Reported by a physician from United States on 2007-10-30
Patient: 45 year old male, weighing 68.9 kg (151.6 pounds)
Adverse reactions / side effects: Thyroid Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Start date: 2005-08-22
End date: 2006-07-16
Ribavirin
Administration route: Oral
Start date: 2005-08-22
End date: 2006-07-23
Other drugs received by patient: Boniva; Potassium Phosphates; Monosodium Phosphate; Norvasc; Tramadol HCL; Atacand; Motrin
Adverse event in receiving Ribavirin
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30
Patient:
Adverse reactions / side effects: Rash, Delusion
Suspect drug(s):
Pegasys
Start date: 2007-10-04
Ribavirin
Start date: 2007-10-04
Adverse event in 44 year old female receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: 44 year old female
Adverse reactions / side effects: Productive Cough, Weight Decreased, Pyrexia, Hyperhidrosis, Faeces Discoloured, Injection Site Erythema, Muscle Spasms, Back Pain, Blood Urine Present, Anaemia, Eye Inflammation, Nasal Congestion, Injection Site Bruising, Hypoaesthesia, Parosmia, Feeding Disorder, Constipation, Abdominal Pain Upper, Fatigue, Skin Lesion, Dizziness, Pharyngolaryngeal Pain, Injection Site Rash, White Blood Cell Count Decreased, Dyspnoea, Vomiting, Nausea, Panic Attack, Arthralgia, Diarrhoea, Bronchitis, Asthenia, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
Pegasys
Start date: 2007-05-23
Ribavirin
Start date: 2007-05-23
End date: 2007-06-14
Ribavirin
Start date: 2007-06-14
Other drugs received by patient: Xanax; Atenolol; Imitrex; Excedrin (Migraine); Alka Seltzer; Unspecified Drug; Pepto Bismol; Muscle Relaxant
Adverse event in 41 year old female receiving Ribavirin
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: 41 year old female
Adverse reactions / side effects: Thrombosis, Pneumonia, Haemoptysis, Anaemia, Wegener's Granulomatosis, Pulmonary Embolism, Pulmonary Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg; qw; sc
Indication: Hepatitis C
Start date: 2004-07-01
End date: 2004-10-30
Ribavirin
Dosage: 6 df; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2004-07-01
End date: 2004-11-02
Other drugs received by patient: Liquibid; Maxzide; Bextra; Tylenol (Caplet); Tums; Ibuprofen; Augmentin '125'; Unspecified Therapeutic Agent
Adverse event in 46 year old male receiving Ribavirin
Reported by a physician from United States on 2007-10-29
Patient: 46 year old male, weighing 88.7 kg (195.1 pounds)
Adverse reactions / side effects: Biliary Dyskinesia
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Dosage: administered weekly.
Start date: 2006-11-10
Ribavirin
Administration route: Oral
Start date: 2006-11-10
End date: 2007-07-17
Other drugs received by patient: Lexapro; Buspar; Trazodone HCL; SOY Protein; Advil; Vitamin E; Ascorbic Acid; Amino Acid INJ; Multivitamin NOS; Vitamin B-12; Aspirin
Adverse event in 53 year old female receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 53 year old female, weighing 77.1 kg (169.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Aphasia, Hypoglycaemia, Headache, Constipation, Loss of Consciousness, Fatigue, Injection Site Erythema, Oedema Peripheral, Blindness Unilateral, Abdominal Distension, Blindness Transient, Mood Swings, Crying, White Blood Cell Count Decreased, Vomiting, Angina Pectoris, Nausea, Anaemia, Injection Site Pruritus, Eye Pain, Tremor, Anxiety, Increased Tendency TO Bruise, Insomnia, Asthenia, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: ;sc
Indication: Hepatitis C
Start date: 2007-04-06
Ribavirin
Dosage: ;po
Administration route: Oral
Indication: Hepatitis
Start date: 2007-04-06
Other drugs received by patient: Antidepressants; Pain Medication; Inhaler
Adverse event in male receiving Ribavirin
Reported by a physician from United States on 2007-10-29
Patient: male, weighing 108.0 kg (237.6 pounds)
Adverse reactions / side effects: Liver Function Test Abnormal
Adverse event resulted in: disablity
Suspect drug(s):
HCV-796
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Peginterferon Alfa-2B
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Ribavirin
Dosage: 1400 mg daily
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-03-25
Ribavirin
Dosage: 1000 mg daily
Administration route: Oral
Start date: 2007-03-26
End date: 2007-03-28
Ribavirin
Dosage: 800 mg daily
Administration route: Oral
Start date: 2007-03-29
End date: 2007-06-26
Other drugs received by patient: Salbutamol; Folic Acid; Ibuprofen; Vicodin
Adverse event in 44 year old male receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 44 year old male, weighing 107.0 kg (235.5 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Weight Decreased, Nightmare, LIP DRY, Chapped Lips, Headache, Hyperhidrosis, Malaise, Hallucination, Visual, Insomnia, Dehydration, Platelet Count Decreased, Anger, Dizziness
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Start date: 2007-07-12
End date: 2007-10-16
Ribavirin
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-07-12
End date: 2007-10-16
Zolpidem Tartrate
Indication: Insomnia
Adverse event in 66 year old female receiving Ribavirin
Reported by a physician from United States on 2007-10-26
Patient: 66 year old female, weighing 69.7 kg (153.3 pounds)
Adverse reactions / side effects: Guillain-Barre Syndrome, Pneumonia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Dosage: prefilled syringe.
Start date: 2005-04-22
End date: 2005-07-27
PEG-Interferon Alfa 2A (RO 25-8310)
Start date: 2005-08-12
End date: 2005-09-02
Ribavirin
Administration route: Oral
Start date: 2005-04-22
End date: 2005-07-27
Ribavirin
Dosage: form reported as pill.
Administration route: Oral
Start date: 2005-08-12
End date: 2005-09-02
Other drugs received by patient: Tylenol (Caplet); Norco; Nortriptyline HCL; Neuroton; Colace; Senokot
Adverse event in 58 year old female receiving Ribavirin
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 58 year old female, weighing 84.8 kg (186.6 pounds)
Adverse reactions / side effects: Blood Bilirubin Increased, Lymphocyte Count Increased, Gastritis Erosive, Myocardial Ischaemia, RED Cell Distribution Width Increased, Colonic Polyp, Duodenitis, Blood Calcium Decreased, Haematocrit Decreased, Large Intestinal Ulcer, RED Blood Cell Count Decreased, Aortic Arteriosclerosis, Irritable Bowel Syndrome, Blood Glucose Increased, Alanine Aminotransferase Increased, Haemorrhoids, Blood Chloride Increased, Blood Bicarbonate Decreased, Blood Thyroid Stimulating Hormone Decreased, Renal Cyst, Haemoglobin Decreased, Blood Potassium Decreased, Hepatic Cyst, Aspartate Aminotransferase Increased, Hypothyroidism, Platelet Count Decreased, Bilirubin Conjugated Increased, Leukopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Infergen
Dosage: 9 ug;qd;sc
Indication: Hepatitis C
Start date: 2007-01-17
End date: 2007-05-01
Ribavirin
Dosage: 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-01-17
Other drugs received by patient: Synthroid; Lexapro; Milk Thistle; Xanax; Oxycodone HCL; Protonix; Diazepam
Adverse event in 55 year old male receiving Ribavirin
Reported by a physician from Canada on 2007-10-26
Patient: 55 year old male, weighing 107.0 kg (235.4 pounds)
Adverse reactions / side effects: Hepatic Encephalopathy
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Start date: 2007-02-03
PEG-Interferon Alfa 2A (RO 25-8310)
Start date: 2007-04-17
PEG-Interferon Alfa 2A (RO 25-8310)
End date: 2007-10-15
Ribavirin
Dosage: given as six tabs twice daily.
Administration route: Oral
Start date: 2007-02-03
End date: 2007-02-18
Ribavirin
Dosage: dose decreased to two tabs twice daily.
Administration route: Oral
Start date: 2007-02-19
Ribavirin
Administration route: Oral
End date: 2007-10-15
Other drugs received by patient: Atacand; Hydrochlorothiazide; Glyburide; Metformin; Clonazepam; Terazosin HCL
Adverse event in receiving Ribavirin
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient:
Adverse reactions / side effects: Amyloidosis
Suspect drug(s):
PEG-Intron
Dosage: ;sc
Indication: Drug USE FOR Unknown Indication
Ribavirin
Dosage: ;po
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 50 year old female receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 50 year old female
Adverse reactions / side effects: Back Pain, Dyspnoea, Lymphadenopathy, Nausea, Facial Pain, Throat Tightness, Abdominal Pain Upper, Oropharyngeal Spasm, Tremor, Vaginal Haemorrhage, Gingival Pain, Throat Irritation, Dysuria, Systemic Lupus Erythematosus, Asthenia, White Blood Cell Count Increased
Suspect drug(s):
PEG-Interferon A-2A (RO 25-8310)
Dosage: reported as pegasys therapy.
Start date: 2007-03-21
Ribavirin
Dosage: reported dose 800 mg per day of ^copegus^
Start date: 2007-03-21
Other drugs received by patient: Cymbalta; Elavil
Adverse event in 48 year old male receiving Ribavirin
Reported by a consumer/non-health professional from United States on 2007-10-25
Patient: 48 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased, Blood Urine Present, Vomiting, Urinary Tract Obstruction, RED Blood Cell Count Decreased, Diarrhoea, Dysuria, Dehydration, Insomnia, Platelet Count Decreased, Depression, Treatment Failure, Feeling Abnormal, Muscle Spasms, Hypersomnia
Suspect drug(s):
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-14
Pegasys
Indication: Hepatitis C
End date: 2007-10-05
Pegasys
Start date: 2006-12-01
End date: 2007-07-01
Pegasys
Dosage: strength reported as 180 mcg/0.5cc.
Start date: 2006-03-14
End date: 2006-09-11
Ribavirin
End date: 2007-10-05
Wellbutrin
Administration route: Oral
Indication: Depression
Start date: 2006-01-01
Wellbutrin
Administration route: Oral
Other drugs received by patient: Klonopin; Lexapro; Oxycontin; Atenolol; Xanax; Protonix
Adverse event in male receiving Ribavirin
Reported by a pharmacist from United States on 2007-10-25
Patient: male
Adverse reactions / side effects: Haemoglobin Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Ribavirin
Dosage: 600mg am 400mg pm po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-24
End date: 2007-10-07
Trizivir
Dosage: fixed dose bid po
Administration route: Oral
Indication: HIV Infection
Adverse event in 52 year old male receiving Ribavirin
Reported by a physician from United States on 2007-10-25
Patient: 52 year old male, weighing 69.9 kg (153.7 pounds)
Adverse reactions / side effects: Weight Decreased, Nausea, Sensation of Heaviness, Chills, Hypotension, Stomach Discomfort, Headache, Pyrexia, Pallor, Fatigue, Dehydration, Photophobia, Feeling Abnormal, Decreased Appetite
Suspect drug(s):
Interferon Alfacon-1
Dosage: 15 ug; qd; sc
Indication: Hepatitis C
Start date: 2006-07-11
End date: 2006-07-28
Ribavirin
Dosage: 600 mg; qam; po, 200 mg, qpm; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-07-11
End date: 2006-07-28
Ribavirin
Dosage: 600 mg; qam; po, 200 mg, qpm; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-07-11
End date: 2006-07-28
Other drugs received by patient: Zoloft; Phenobarbital TAB
|
